INDIAN BENCHMARK
opened on a flat note with a negative bias on account of weakness in
index heavyweights like L&T, HDFC twins and Maruti Suzuki. The
market will pay close attention to the January IIP and Feb CPI data
today.
FURTHER, Havells India is planning to raise money by listing its European subsidiary Sylvania Global on the London Stock Exchange to fund acquisitions of brands or companies in Latin America and Europe. Ranbaxy Laboratories is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca's heartburn drug Nexium.
Trend in FII flows: The FIIs were net buyers of Rs.1471cr in the cash segment on Tuesday while the domestic institutional investors (DIIs) were net sellers of Rs. 1331cr, as per the provisional figures released by the NSE.
FURTHER, Havells India is planning to raise money by listing its European subsidiary Sylvania Global on the London Stock Exchange to fund acquisitions of brands or companies in Latin America and Europe. Ranbaxy Laboratories is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca's heartburn drug Nexium.
Trend in FII flows: The FIIs were net buyers of Rs.1471cr in the cash segment on Tuesday while the domestic institutional investors (DIIs) were net sellers of Rs. 1331cr, as per the provisional figures released by the NSE.
!!! Hurry Up !!!
these are holi bonanza offer !!!
these are holi bonanza offer !!!
For More Details :-
www.capitalstars.com
www.commoditytipsproviderindore.blogspot.com
www.stocktipsindiamarket.blogspot.com
Call me on 09907222727
www.capitalstars.com
www.commoditytipsproviderindore.blogspot.com
www.stocktipsindiamarket.blogspot.com
Call me on 09907222727
0 comments:
Post a Comment